Biovail Sues Sun Over Cardizem ANDA
Biovail filed the suit Friday in the U.S. District Court for the District of New Jersey, seeking an injunction preventing Sun's plans from moving forward.
According to the suit, Sun has filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to market a generic equivalent of Cardizem in several dosages.
Sun has sent letters...
To view the full article, register now.